These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


Pubmed for Handhelds

PUBMED FOR HANDHELDS

Journal Abstract Search

677 related items for PubMed ID: 8722369

  • 1. Polymerase chain reaction is highly predictive of relapse in patients following T cell-depleted allogeneic bone marrow transplantation for chronic myeloid leukemia.
    Mackinnon S, Barnett L, Heller G.
    Bone Marrow Transplant; 1996 Apr; 17(4):643-7. PubMed ID: 8722369
    [Abstract] [Full Text] [Related]

  • 2. Detection of bcr/abl transcripts by RT-PCR and their colorimetric evaluation in chronic myeloid leukemia patients receiving allogeneic bone marrow transplantation.
    Santini V, Zoccolante A, Bosi A, Guidi S, Saccardi R, Vannucchi AM, Martinazzo G, Bernabei PA, Ferrini PR.
    Haematologica; 1996 Apr; 81(3):201-7. PubMed ID: 8767524
    [Abstract] [Full Text] [Related]

  • 3. Molecular analysis of transient cytogenetic relapse after allogeneic bone marrow transplantation for chronic myeloid leukaemia.
    Lin F, Kirkland MA, van Rhee FV, Chase A, Coulthard S, Bungey J, Goldman JM, Cross NC.
    Bone Marrow Transplant; 1996 Dec; 18(6):1147-52. PubMed ID: 8971386
    [Abstract] [Full Text] [Related]

  • 4. Myeloid mixed chimerism is associated with relapse in bcr-abl positive patients after unmanipulated allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Román J, Serrano J, Jiménez A, Castillejo JA, Reina ML, González MG, Rodríguez MC, García I, Sánchez J, Maldonado J, Torres A.
    Haematologica; 2000 Feb; 85(2):173-80. PubMed ID: 10681725
    [Abstract] [Full Text] [Related]

  • 5. Persistent donor chimaerism is consistent with disease-free survival following BMT for chronic myeloid leukaemia.
    Gardiner N, Lawler M, O'Riordan J, DeArce M, Humphries P, McCann SR.
    Bone Marrow Transplant; 1997 Aug; 20(3):235-41. PubMed ID: 9257892
    [Abstract] [Full Text] [Related]

  • 6.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 7. The evolving role of bone marrow transplantation in the treatment of chronic myelogenous leukemia.
    Delage R, Ritz J, Anderson KC.
    Hematol Oncol Clin North Am; 1990 Apr; 4(2):369-88. PubMed ID: 2182597
    [Abstract] [Full Text] [Related]

  • 8. Detection of minimal residual disease and persistence of host-type hematopoiesis: a study in 28 patients after sex-mismatched, non-T cell-depleted allogeneic bone marrow transplantation for Philadelphia-chromosome positive chronic myelogenous leukemia.
    Elmaagacli AH, Becks HW, Beelen DW, Stockova J, Bützler R, Opalka B, Schaefer UW.
    Bone Marrow Transplant; 1995 Dec; 16(6):823-9. PubMed ID: 8750276
    [Abstract] [Full Text] [Related]

  • 9. Qualitative assessment of mixed chimerism after allogeneic bone marrow transplantation with regard to leukemic relapse.
    Kögler G, Hernandez A, Heyll A, Wolf HH, Wernet P.
    Cancer Detect Prev; 1996 Dec; 20(6):601-9. PubMed ID: 8939346
    [Abstract] [Full Text] [Related]

  • 10.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 11. Frequent detection of BCR-ABL specific mRNA in patients with chronic myeloid leukemia (CML) following allogeneic and syngeneic bone marrow transplantation (BMT).
    Gaiger A, Lion T, Kalhs P, Mitterbauer G, Henn T, Haas O, Födinger M, Kier P, Forstinger C, Quehenberger P.
    Leukemia; 1993 Nov; 7(11):1766-72. PubMed ID: 8231244
    [Abstract] [Full Text] [Related]

  • 12. [Minimal residual disease in chronic myeloid leukemia in patients with long survival after allogeneic bone marrow transplantation].
    García A, Román J, Brunet S, Andrés P, Baiget M, Torres A.
    Med Clin (Barc); 1995 Mar 25; 104(11):401-6. PubMed ID: 7715257
    [Abstract] [Full Text] [Related]

  • 13. Minimal residual disease in chronic myeloid leukaemia.
    Cross NC.
    Hematol Cell Ther; 1998 Oct 25; 40(5):224-8. PubMed ID: 9844816
    [Abstract] [Full Text] [Related]

  • 14. Detection of bcr-abl mRNA in single progenitor colonies from patients with chronic myeloid leukemia by PCR: comparison with cytogenetics and PCR from uncultured cells.
    Schulze E, Krahl R, Thalmeier K, Helbig W.
    Exp Hematol; 1995 Dec 25; 23(14):1649-54. PubMed ID: 8542960
    [Abstract] [Full Text] [Related]

  • 15. Minimal residual disease after bone marrow transplantation for chronic myelogenous leukemia and implications for graft-versus-leukemia effect: a review of recent results.
    Miyamura K, Barrett AJ, Kodera Y, Saito H.
    Bone Marrow Transplant; 1994 Aug 25; 14(2):201-9. PubMed ID: 7994233
    [Abstract] [Full Text] [Related]

  • 16. Distinct patterns of minimal residual disease associated with graft-versus-host disease after allogeneic bone marrow transplantation for chronic myelogenous leukemia.
    Pichert G, Roy DC, Gonin R, Alyea EP, Bélanger R, Gyger M, Perreault C, Bonny Y, Lerra I, Murray C.
    J Clin Oncol; 1995 Jul 25; 13(7):1704-13. PubMed ID: 7602361
    [Abstract] [Full Text] [Related]

  • 17. Detection of CBFbeta/MYH11 fusion transcripts in patients with inv(16) acute myeloid leukemia after allogeneic bone marrow or peripheral blood progenitor cell transplantation.
    Elmaagacli AH, Beelen DW, Kroll M, Trzensky S, Stein C, Schaefer UW.
    Bone Marrow Transplant; 1998 Jan 25; 21(2):159-66. PubMed ID: 9489633
    [Abstract] [Full Text] [Related]

  • 18.
    ; . PubMed ID:
    [No Abstract] [Full Text] [Related]

  • 19. Survival in first or second remission after lymphocyte-depleted transplantation for Philadelphia chromosome-positive CML in first chronic phase.
    Schattenberg A, Preijers F, Mensink E, Bär B, Schaap N, Geurts van Kessel A, van der Maazen R, de Witte T.
    Bone Marrow Transplant; 1997 Jun 25; 19(12):1205-12. PubMed ID: 9208114
    [Abstract] [Full Text] [Related]

  • 20. bcr/abl chimeric transcript in patients in remission after marrow transplantation for chronic myeloid leukemia: higher frequency of detection and slower clearance in patients grafted in advanced disease as compared to patients grafted in chronic phase.
    Frassoni F, Martinelli G, Saglio G, Sessarego M, Podestà M, Piaggio G, Farabegoli P, Zaccaria A, Testoni N, Remiddi C.
    Bone Marrow Transplant; 1995 Oct 25; 16(4):595-601. PubMed ID: 8528178
    [Abstract] [Full Text] [Related]

    Page: [Next] [New Search]
    of 34.